SEC Comment Letter 0000000000-24-011582 to ROCKWELL MEDICAL, INC. (RMTI) (CIK 0001041024) (RMTI)
ROCKWELL MEDICAL, INC. (RMTI) (CIK 0001041024)
Date: Oct. 15, 2024 · CIK: 0001041024 · Accession: 0000000000-24-011582
AI Filing Summary & Sentiment
File numbers found in text: 333-282538
Letter
October 15, 2024 Mark Strobeck Chief Executive Officer Rockwell Medical, Inc. 30142 S. Wixom Road Wixom, Michigan 48393 Re:Rockwell Medical, Inc. Registration Statement on Form S-3 Filed October 8, 2024 File No. 333-282538 Dear Mark Strobeck: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Ryan A. Murr
Show Raw Text
October 15, 2024
Mark Strobeck
Chief Executive Officer
Rockwell Medical, Inc.
30142 S. Wixom Road
Wixom, Michigan 48393
Re:Rockwell Medical, Inc.
Registration Statement on Form S-3
Filed October 8, 2024
File No. 333-282538
Dear Mark Strobeck:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Ryan A. Murr